# Invesco Biotechnology & Genome ETF

Invesco Biotechnology & Genome ETF is a ETF series of Invesco Exchange-Traded Fund Trust (series S000003026). Net assets $247.4M as of 2026-04-30. Index fund.

## Profile

- Series ID: S000003026
- Registrant: Invesco Exchange-Traded Fund Trust
- LEI: 549300TC80GXFQLM7W73
- Net assets: $247.4M
- Total assets: $285.1M
- As of: 2026-04-30
- Type: ETF, Index

## Advisers

- [Invesco Capital Management LLC (Advisor)](https://search.stillhousedata.com/firm/125601)

## Top holdings (33 reported)

_Showing 15 of 33 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| Invesco Private Prime Fund | — | $27.0M | 1091.61% |
| [United Therapeutics Corp.](https://search.stillhousedata.com/security/91307C102) | — | $15.5M | 628.48% |
| [Illumina, Inc.](https://search.stillhousedata.com/security/452327109) | — | $13.3M | 537.08% |
| [Biogen Inc.](https://search.stillhousedata.com/security/09062X103) | — | $12.5M | 505.18% |
| [Incyte Corp.](https://search.stillhousedata.com/security/45337C102) | — | $12.1M | 491.01% |
| [Alnylam Pharmaceuticals, Inc.](https://search.stillhousedata.com/security/02043Q107) | — | $12.0M | 484.23% |
| [Regeneron Pharmaceuticals, Inc.](https://search.stillhousedata.com/security/75886F107) | — | $11.8M | 476.86% |
| [Amgen Inc.](https://search.stillhousedata.com/security/031162100) | — | $11.7M | 471.00% |
| [Gilead Sciences, Inc.](https://search.stillhousedata.com/security/375558103) | — | $11.4M | 461.54% |
| Invesco Private Government Fund | — | $10.4M | 420.12% |
| [BioCryst Pharmaceuticals, Inc.](https://search.stillhousedata.com/security/09058V103) | — | $8.5M | 341.93% |
| [Catalyst Pharmaceuticals, Inc.](https://search.stillhousedata.com/security/14888U101) | — | $8.2M | 330.34% |
| [Arrowhead Pharmaceuticals, Inc.](https://search.stillhousedata.com/security/04280A100) | — | $8.1M | 327.84% |
| [Protagonist Therapeutics, Inc.](https://search.stillhousedata.com/security/74366E102) | — | $8.0M | 321.72% |
| [TG Therapeutics, Inc.](https://search.stillhousedata.com/security/88322Q108) | — | $7.8M | 314.52% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-04-30 | $247.4M |
| 2026-01-31 | $263.0M |
| 2025-10-31 | $234.1M |
| 2025-07-31 | $225.4M |
| 2025-04-30 | $221.3M |
| 2025-01-31 | $255.2M |
| 2024-10-31 | $257.1M |
| 2024-07-31 | $269.9M |

## More

- [Registrant: Invesco Exchange-Traded Fund Trust](https://search.stillhousedata.com/registrant/1209466)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000003026.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.